Immune mechanisms of group B coxsackievirus induced viral myocarditis

References

• Goetzke CC, Althof N, Neumaier HL, et al. Mitigated viral myocarditis in A/J mice by the immunoproteasome inhibitor ONX 0914 depends on inhibition of systemic inflammatory responses in CoxsackievirusB3 infection. Basic Res Cardiol. 2021;116(1):7. DOI:10.1007/s00395-021-00848-w
   PubMed Web of Science ®Google Scholar
• Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;386(9995):743–11. DOI:10.1016/S0140-6736(15)60692-4
   PubMed Web of Science ®Google Scholar
• Sinagra G, Porcari A, Gentile P, et al. Viral presence-guided immunomodulation in lymphocytic myocarditis: an update. Eur J Heart Fail. 2021;23(2):211–216. DOI:10.1002/ejhf.1969
   PubMed Web of Science ®Google Scholar
• Zhao J, Yin M, Deng H, et al. Cardiac gab1 deletion leads to dilated cardiomyopathy associated with mitochondrial damage and cardiomyocyte apoptosis. Cell Death Differ. 2016;23(4):695–706. DOI:10.1038/cdd.2015.143
   PubMed Web of Science ®Google Scholar
• Noutsias M, Rohde M, Göldner K, et al. Expression of functional T-cell markers and T-cell receptor Vbeta repertoire in endomyocardial biopsies from patients presenting with acute myocarditis and dilated cardiomyopathy. Eur J Heart Fail. 2011;13(6):611–618. DOI:10.1093/eurjhf/hfr014
   PubMed Web of Science ®Google Scholar
• Grun S, Schumm J, Greulich S, et al. Long-term follow-up of biopsy-proven viral myocarditis. J Am Coll Cardiol. 2012;59(18):1604–1615. DOI:10.1016/j.jacc.2012.01.007
   PubMed Web of Science ®Google Scholar
• Jensen LD, Marchant DJ. Emerging pharmacologic targets and treatments for myocarditis. Pharmacol Ther. 2016;161:40–51.
   PubMed Web of Science ®Google Scholar
• Wang X, Li M, Yu Y. FTY720 alleviates coxsackievirus B3-induced myocarditis and inhibits viral replication through regulating sphingosine 1-phosphate receptors and AKT/caspase-3 pathways. J Cell Physiol. 2019;234(10):18029–18040.
   PubMed Web of Science ®Google Scholar
• Ho HT, Peischard S, Strutz-Seebohm N, et al. Virus-host interactions of enteroviruses and parvovirus B19 in myocarditis. Cell Physiol Biochem. 2021;55(6):679–703.
   PubMedGoogle Scholar
• Meyer IS, Goetzke CC, Kespohl M, et al. Silencing the CSF-1 axis using nanoparticle encapsulated siRNA mitigates viral and autoimmune myocarditis. Front Immunol. 2018;9:2303.
   PubMed Web of Science ®Google Scholar
• Negishi H, Osawa T, Ogami K, et al. A critical link between toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity. Proc Natl Acad Sci U S A. 2008;105(51):20446–20451. DOI:10.1073/pnas.0810372105
   PubMed Web of Science ®Google Scholar
• Zarak-Crnkovic M, Kania G, Jaźwa-Kusior A. Heart non-specific effector CD4+T cells protect from postinflammatory fibrosis and cardiac dysfunction in experimental autoimmune myocarditis. Basic Res Cardiol. 2019;115(1):6.
   PubMed Web of Science ®Google Scholar
• Pinkert S, Dieringer B, Klopfleisch R, et al. Early treatment of coxsackievirus B3-infected animals with soluble coxsackievirus-adenovirus receptor inhibits development of chronic coxsackievirus B3 cardiomyopathy. Circ Heart Fail. 2019;12(11):e005250. DOI:10.1161/CIRCHEARTFAILURE.119.005250
   PubMed Web of Science ®Google Scholar
• Cooper LT. Myocarditis. N Engl J Med. 2009;360(15):1526–1538.
   PubMed Web of Science ®Google Scholar
• Andreoletti L, Leveque N, Boulagnon C, et al. Viral causes of human myocarditis. Arch Cardiovasc Dis. 2009;102(6–7):559–568. DOI:10.1016/j.acvd.2009.04.010
   PubMed Web of Science ®Google Scholar
• Huber SA. Viral myocarditis and dilated cardiomyopathy: etiology and pathogenesis. Curr Pharm Des. 2016;22(4):408–426.
   PubMed Web of Science ®Google Scholar
• Ntusi NAB. HIV and myocarditis. Curr Opin HIV AIDS. 2017;12(6):561–565.
   PubMed Web of Science ®Google Scholar
• Pinkert S, Pryshliak M, Pappritz K, et al. Development of a new mouse model for coxsackievirus-induced myocarditis by attenuating coxsackievirus B3 virulence in the pancreas. Cardiovasc Res. 2020;116(10):1756–1766. DOI:10.1093/cvr/cvz259
   PubMed Web of Science ®Google Scholar
• He Y, Chipman P, Howitt J, et al. Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor. Nat Struct Biol. 2001;8(10):874–878. DOI:10.1038/nsb1001-874
   PubMedGoogle Scholar
• Pinkert S. Prevention of cardiac dysfunction in acute coxsackievirus B3 cardiomyopathy by inducible expression of a soluble coxsackievirus-adenovirus receptor. Circulation. 2009;120(23):2358–2366.
   PubMed Web of Science ®Google Scholar
• Yajima T, Knowlton KU. Viral myocarditis: from the perspective of the virus. Circulation. 2009;119(19):2615–2624.
   PubMed Web of Science ®Google Scholar
• Das BB, Prusty BK, Niu J, et al. Detection of parvovirus B19 and human herpesvirus 6 in pediatric dilated cardiomyopathy: impact after heart transplantation. Ann Pediatr Cardiol. 2020;13(4):301–308. DOI:10.4103/apc.APC_124_19
   PubMed Web of Science ®Google Scholar
• Santonja C, Santos-Briz A, Palmedo G, et al. Detection of human parvovirus B19 DNA in 22% of 1815 cutaneous biopsies of a wide variety of dermatological conditions suggests viral persistence after primary infection and casts doubts on its pathogenic significance. Br J Dermatol. 2017;177(4):1060–1065. DOI:10.1111/bjd.15382
   PubMed Web of Science ®Google Scholar
• Brody H. Influenza. Nature. 2019;573(7774):S49.
   PubMed Web of Science ®Google Scholar
• Chen C, Zhou Y, Wang DW. SARS-CoV-2: a potential novel etiology of fulminant myocarditis. Herz. 2020;45(3):230–232.
   PubMed Web of Science ®Google Scholar
• Long B, Brady WJ, Koyfman A, et al. Cardiovascular complications in COVID-19. Am J Emerg Med. 2020;38(7):1504–1507. DOI:10.1016/j.ajem.2020.04.048
   PubMed Web of Science ®Google Scholar
• Gentile P, Merlo M, Peretto G, et al. Post-discharge arrhythmic risk stratification of patients with acute myocarditis and life-threatening ventricular tachyarrhythmias. Eur J Heart Fail. 2021;23(12):2045–2054. DOI:10.1002/ejhf.2288
   PubMed Web of Science ®Google Scholar
• Mackman N, Antoniak S. Roles of PAR1 and PAR2 in viral myocarditis. Thromb Res. 2014;133 Suppl 1:S18–20.
   PubMed Web of Science ®Google Scholar
• Chathuranga K, Weerawardhana A, Dodantenna N, et al. Regulation of antiviral innate immune signaling and viral evasion following viral genome sensing. Exp Mol Med. 2021;53(11):1647–1668. DOI:10.1038/s12276-021-00691-y
   PubMed Web of Science ®Google Scholar
• Kim CU, Jeong YJ, Lee P, et al. Extracellular nucleoprotein exacerbates influenza virus pathogenesis by activating toll-like receptor 4 and the NLRP3 inflammasome. Cell Mol Immunol. 2022;19(6):715–725. DOI:10.1038/s41423-022-00862-5
   PubMed Web of Science ®Google Scholar
• Ouyang J, Hu J, Chen JL, et al. lncRnas regulate the innate immune response to viral infection. Wiley Interdiscip Rev RNA. 2016;7(1):129–143. DOI:10.1002/wrna.1321
   PubMed Web of Science ®Google Scholar
• Dege C, Fegan KH, Creamer JP, et al. Potently cytotoxic natural killer cells initially emerge from erythro-myeloid progenitors during mammalian development. Dev Cell. 2020;53(2):229–239.e7. DOI:10.1016/j.devcel.2020.02.016
   PubMed Web of Science ®Google Scholar
• Mande P, Zirak B, Ko WC, et al. Fas ligand promotes an inducible TLR-dependent model of cutaneous lupus-like inflammation. J Clin Invest. 2018;128(7):2966–2978. DOI:10.1172/JCI98219
   PubMed Web of Science ®Google Scholar
• Nandakumar R, Paludan SR. Catching the adaptor-WDFY1, a new player in the TLR-TRIF pathway. EMBO Rep. 2015;16(4):397–398.
   PubMed Web of Science ®Google Scholar
• Wang M, Qi Y, Cao Y, et al. Domain fusion TLR2-4 enhances the autophagy-dependent clearance of in the genetic engineering goat. Elife. 2022;11:e78044.
   PubMed Web of Science ®Google Scholar
• Chen J, Li J, Yiu JHC, et al. TRIF-dependent toll-like receptor signaling suppresses transcription in hepatocytes and prevents diet-induced hepatic steatosis. Sci Signal. 2017;10(491):eaal3336. DOI:10.1126/scisignal.aal3336
   PubMed Web of Science ®Google Scholar
• Song X, Liu S, Wang W, et al. E3 ubiquitin ligase RNF170 inhibits innate immune responses by targeting and degrading TLR3 in murine cells. Cell Mol Immunol. 2020;17(8):865–874. DOI:10.1038/s41423-019-0236-y
   PubMed Web of Science ®Google Scholar
• Hung YF, Chen CY, Shih YC, et al. Endosomal TLR3, TLR7, and TLR8 control neuronal morphology through different transcriptional programs. J Cell Biol. 2018;217(8):2727–2742. DOI:10.1083/jcb.201712113
   PubMed Web of Science ®Google Scholar
• Jenke A, Holzhauser L, Lobel M, et al. Adiponectin promotes coxsackievirus B3 myocarditis by suppression of acute anti-viral immune responses. Basic Res Cardiol. 2014;109(3):408. DOI:10.1007/s00395-014-0408-y
   PubMed Web of Science ®Google Scholar
• Weithauser A, Bobbert P, Antoniak S, et al. Protease-activated receptor-2 regulates the innate immune response to viral infection in a coxsackievirus B3-induced myocarditis. J Am Coll Cardiol. 2013;62(19):1737–1745. DOI:10.1016/j.jacc.2013.05.076
   PubMed Web of Science ®Google Scholar
• Antoniak S, Owens AP 3rd, Baunacke M, et al. PAR-1 contributes to the innate immune response during viral infection. J Clin Invest. 2013;123(3):1310–1322. DOI:10.1172/JCI66125
   PubMed Web of Science ®Google Scholar
• Reynolds JM, Martinez GJ, Chung Y, et al. Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation. Proc Natl Acad Sci U S A. 2012;109(32):13064–13069. DOI:10.1073/pnas.1120585109
   PubMed Web of Science ®Google Scholar
• Epelman S, Liu PP, Mann DL. Role of innate and adaptive immune mechanisms in cardiac injury and repair. Nat Rev Immunol. 2015;15(2):117–129.
   PubMed Web of Science ®Google Scholar
• Rienks M, Papageorgiou A, Wouters K, et al. A novel 72-kDa leukocyte-derived osteoglycin enhances the activation of toll-like receptor 4 and exacerbates cardiac inflammation during viral myocarditis. Cell Mol Life Sci. 2017;74(8):1511–1525. DOI:10.1007/s00018-016-2423-7
   PubMed Web of Science ®Google Scholar
• Xie SY, Wang QQ, Xu M, et al. Activation of toll-like receptor 7 provides cardioprotection in septic cardiomyopathy-induced systolic dysfunction. Clin Transl Med. 2021;11(1):e266. DOI:10.1002/ctm2.266
   PubMed Web of Science ®Google Scholar
• Kim TW, Staschke K, Bulek K, et al. A critical role for IRAK4 kinase activity in toll-like receptor-mediated innate immunity. J Exp Med. 2007;204(5):1025–1036. DOI:10.1084/jem.20061825
   PubMed Web of Science ®Google Scholar
• Valaperti A, Nishii M, Liu Y, et al. Innate immune interleukin-1 receptor-associated kinase 4 exacerbates viral myocarditis by reducing CCR5(+) CD11b(+) monocyte migration and impairing interferon production. Circulation. 2013;128(14):1542–1554. DOI:10.1161/CIRCULATIONAHA.113.002275
   PubMed Web of Science ®Google Scholar
• Mackman RL, Mish M, Chin G, et al. Discovery of GS-9688 (selgantolimod) as a potent and selective oral toll-like receptor 8 agonist for the treatment of chronic hepatitis B. J Med Chem. 2020;63(18):10188–10203. DOI:10.1021/acs.jmedchem.0c00100
   PubMed Web of Science ®Google Scholar
• Rivadeneyra L, Charo N, Kviatcovsky D, et al. Role of neutrophils in CVB3 infection and viral myocarditis. J Mol Cell Cardiol. 2018;125:149–161.
   PubMed Web of Science ®Google Scholar
• Kawai T, Akira S. Signaling to NF-kappaB by toll-like receptors. Trends Mol Med. 2007;13(11):460–469.
   PubMed Web of Science ®Google Scholar
• Shi J, Wong J, Piesik P, et al. Cleavage of sequestosome 1/p62 by an enteroviral protease results in disrupted selective autophagy and impaired NFKB signaling. Autophagy. 2013;9(10):1591–1603. DOI:10.4161/auto.26059
   PubMed Web of Science ®Google Scholar
• Colonna M. TLR pathways and IFN-regulatory factors: to each its own. Eur J Immunol. 2007;37(2):306–309.
   PubMed Web of Science ®Google Scholar
• Liu H, Li M, Song Y, et al. TRIM21 restricts coxsackievirus B3 replication, cardiac and pancreatic injury via interacting with MAVS and positively regulating IRF3-mediated type-I interferon production. Front Immunol. 2018;9:2479.
   PubMed Web of Science ®Google Scholar
• Kufer T, Sansonetti P. NLR functions beyond pathogen recognition. Nat Immunol. 2011;12(2):121–128.
   PubMed Web of Science ®Google Scholar
• Chen L, Cao SQ, Lin ZM, et al. NOD-like receptors in autoimmune diseases. Acta Pharmacol Sin. 2021;42(11):1742–1756. DOI:10.1038/s41401-020-00603-2
   PubMed Web of Science ®Google Scholar
• Wang Y, Gao B, Xiong S. Involvement of NLRP3 inflammasome in CVB3-induced viral myocarditis. Am J Physiol Heart Circ Physiol. 2014;307(10):H1438–1447.
   PubMed Web of Science ®Google Scholar
• Bao J, Sun T, Yue Y, et al. Macrophage NLRP3 inflammasome activated by CVB3 capsid proteins contributes to the development of viral myocarditis. Mol Immunol. 2019;114:41–48.
   PubMed Web of Science ®Google Scholar
• Daffu G, Del Pozo CH, O’shea KM, et al. Radical roles for RAGE in the pathogenesis of oxidative stress in cardiovascular diseases and beyond. Int J Mol Sci. 2013;14(10):19891–19910. DOI:10.3390/ijms141019891
   PubMed Web of Science ®Google Scholar
• Muller I, Vogl T, Pappritz K, et al. Pathogenic role of the damage-associated molecular patterns S100A8 and S100A9 in coxsackievirus B3-induced myocarditis. Circ Heart Fail. 2017;10(11):e004125. DOI:10.1161/CIRCHEARTFAILURE.117.004125
   PubMed Web of Science ®Google Scholar
• Huhn MH, Hultcrantz M, Lind K, et al. IFN-gamma production dominates the early human natural killer cell response to coxsackievirus infection. Cell Microbiol. 2008;10(2):426–436. DOI:10.1111/j.1462-5822.2007.01056.x
   PubMed Web of Science ®Google Scholar
• Li S, Ogbomo H, Mansour M, et al. Identification of the fungal ligand triggering cytotoxic PRR-mediated NK cell killing of Cryptococcus and Candida. Nat Commun. 2018;9(1):751–763. DOI:10.1038/s41467-018-03014-4
   PubMedGoogle Scholar
• Morris BJ, Willcox DC, Donlon TA, et al. FOXO3: a major gene for human longevity - a mini-review. Gerontology. 2015;61(6):515–525. DOI:10.1159/000375235
   PubMed Web of Science ®Google Scholar
• Loebel M, Holzhauser L, Hartwig JA, et al. The forkhead transcription factor Foxo3 negatively regulates natural killer cell function and viral clearance in myocarditis. Eur Heart J. 2018;39(10):876–887. DOI:10.1093/eurheartj/ehx624
   PubMed Web of Science ®Google Scholar
• Janeway CA, Medzhitov R. Innate immune recognition. Annu Rev Immunol. 2002;20(1):197–216.
   PubMed Web of Science ®Google Scholar
• Mercier BC, Cottalorda A, Coupet CA, et al. TLR2 engagement on CD8 T cells enables generation of functional memory cells in response to a suboptimal TCR signal. J Immunol. 2009;182(4):1860–1867. DOI:10.4049/jimmunol.0801167
   PubMed Web of Science ®Google Scholar
• Kania G, Siegert S, Behnke S, et al. Innate signaling promotes formation of regulatory nitric oxide-producing dendritic cells limiting T-cell expansion in experimental autoimmune myocarditis. Circulation. 2013;127(23):2285–2294. DOI:10.1161/CIRCULATIONAHA.112.000434
   PubMed Web of Science ®Google Scholar
• Ivanov MB II, Zhou L, et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell. 2006;126(6):1121–1133. DOI:10.1016/j.cell.2006.07.035
   PubMed Web of Science ®Google Scholar
• Seif F, Khoshmirsafa M, Aazami H, et al. The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells. Cell Commun Signal. 2017;15(1):23. DOI:10.1186/s12964-017-0177-y
   PubMed Web of Science ®Google Scholar
• Long Q, Liao YH, Xie Y, et al. Coxsackievirus B3 directly induced Th17 cell differentiation by inhibiting Nup98 expression in patients with acute viral myocarditis. Front Cell Infect Microbiol. 2016;6:171.
   PubMed Web of Science ®Google Scholar
• Yuan J, Yu M, Lin QW, et al. Th17 cells contribute to viral replication in coxsackievirus B3-induced acute viral myocarditis. J Immunol. 2010;185(7):4004–4010. DOI:10.4049/jimmunol.1001718
   PubMed Web of Science ®Google Scholar
• Wei B, Deng Y, Huang Y, et al. IL-10-producing B cells attenuate cardiac inflammation by regulating Th1 and Th17 cells in acute viral myocarditis induced by coxsackie virus B3. Life Sci. 2019;235:116838.
   PubMed Web of Science ®Google Scholar
• Li L, Li L, Xiao L, et al. Progranulin ameliorates coxsackievirus-B3-induced viral myocarditis by downregulating Th1 and Th17 cells. Exp Cell Res. 2018;367(2):241–250. DOI:10.1016/j.yexcr.2018.04.001
   PubMed Web of Science ®Google Scholar
• De-Pu Z, Li-Sha G, Guang-Yi C, et al. The cholinergic anti-inflammatory pathway ameliorates acute viral myocarditis in mice by regulating CD4(+) T cell differentiation. Virulence. 2018;9(1):1364–1376. DOI:10.1080/21505594.2018.1482179
   PubMed Web of Science ®Google Scholar
• Novy P, Huang X, Leonard WJ, et al. Intrinsic IL-21 signaling is critical for CD8 T cell survival and memory formation in response to vaccinia viral infection. J Immunol. 2011;186(5):2729–2738. DOI:10.4049/jimmunol.1003009
   PubMed Web of Science ®Google Scholar
• Liu W, Dienz O, Roberts B, et al. IL-21R expression on CD8+ T cells promotes CD8+ T cell activation in coxsackievirus B3 induced myocarditis. Exp Mol Pathol. 2012;92(3):327–333. DOI:10.1016/j.yexmp.2012.03.009
   PubMed Web of Science ®Google Scholar
• Cordero-Reyes A, Youker K, Trevino A, et al. Full expression of cardiomyopathy is partly dependent on B-cells: a pathway that involves cytokine activation, immunoglobulin deposition, and activation of apoptosis. J Am Heart Assoc. 2016;5(1):e002484. DOI:10.1161/JAHA.115.002484
   PubMed Web of Science ®Google Scholar
• Adamo L, Staloch L, Rocha-Resende C, et al. Modulation of subsets of cardiac B lymphocytes improves cardiac function after acute injury. JCI Insight. 2018;3:e120137.
   PubMed Web of Science ®Google Scholar
• Zhao L, Fu Z. Roles of host immunity in viral myocarditis and dilated cardiomyopathy. J Immunol Res. 2018;7:5301548.
   Google Scholar
• Cen Z, Li Y, Wei B, et al. The role of B cells in regulation of Th cell differentiation in coxsackievirus B3-induced acute myocarditis. Inflammation. 2021;5(44):1949–1960. DOI:10.1007/s10753-021-01472-5
   Google Scholar
• Lu J, Cen Z, Tang Q, et al. The absence of B cells disrupts splenic and myocardial Treg homeostasis in coxsackievirus B3-induced myocarditis. Clin Exp Immunol. 2022;208(1):1–11. DOI:10.1093/cei/uxac015
   PubMed Web of Science ®Google Scholar
• Li Y, Huang Y, Wu W. B cells increase myocardial inflammation by suppressing M2 macrophage polarization in coxsackie virus B3-induced acute myocarditis. Inflammation. 2019;3(42):953–960.
   Google Scholar
• Assomull RG, Prasad SK, Lyne J, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol. 2006;48(10):1977–1985. DOI:10.1016/j.jacc.2006.07.049
   PubMed Web of Science ®Google Scholar
• Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies. Circulation. 2006;113(14):1807–1816. DOI:10.1161/CIRCULATIONAHA.106.174287
   PubMed Web of Science ®Google Scholar
• Kraft L, Erdenesukh T, Sauter M, et al. Blocking the IL-1beta signalling pathway prevents chronic viral myocarditis and cardiac remodeling. Basic Res Cardiol. 2019;114(2):11. DOI:10.1007/s00395-019-0719-0
   PubMed Web of Science ®Google Scholar
• Liu T, Zhang M, Niu H. Astragalus polysaccharide from astragalus melittin ameliorates inflammation via suppressing the activation of TLR-4/NF-κB p65 signal pathway and protects mice from CVB3-induced virus myocarditis. Int J Biol Macromol. 2019;126:179–186.
   PubMed Web of Science ®Google Scholar
• Li Q, Ye W, Huang Z, et al. Effect of IL-6-mediated STAT3 signaling pathway on myocardial apoptosis in mice with dilated cardiomyopathy. Eur Rev Med Pharmaco. 2019;23:3042–3050.
   PubMedGoogle Scholar
• Li Z, Nguyen T, Valaperti A. Human cardiac fibroblasts produce pro‐inflammatory cytokines upon TLRs and RLRs stimulation. Mol Cell Biochem. 2021;476:3241–3252.
   PubMed Web of Science ®Google Scholar
• Guo Y, Wu W, Cen Z, et al. IL-22-producing Th22 cells play a protective role in CVB3-induced chronic myocarditis and dilated cardiomyopathy by inhibiting myocardial fibrosis. Virol J. 2014;11(1):230–241. DOI:10.1186/s12985-014-0230-z
   PubMedGoogle Scholar